EOLS (Evolus, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings
Evolus, Inc. Common Stock (EOLS) is a publicly traded Healthcare sector company. As of May 21, 2026, EOLS trades at $6.59 with a market cap of $432.67M and a P/E ratio of -9.80. EOLS moved +2.26% today. Year to date, EOLS is +8.93%; over the trailing twelve months it is -33.84%. Its 52-week range spans $3.86 to $17.82. Analyst consensus is strong buy with an average price target of $14.50. Rallies surfaces EOLS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns EOLS stock?
Hedge funds tracked by Rallies that own EOLS include Soros Fund and Panagora Asset. The latest tracked quarter is Mar 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Evolus, Inc. Common Stock.
EOLS Key Metrics
Key financial metrics for EOLS
Metric
Value
Price
$6.59
Market Cap
$432.67M
P/E Ratio
-9.80
EPS
$-0.67
Dividend Yield
0.00%
52-Week High
$17.82
52-Week Low
$3.86
Volume
113
Avg Volume
0
Revenue (TTM)
$301.79M
Net Income
$-43.42M
Gross Margin
66.06%
Top Hedge Funds Holding EOLS
Soros Fund holds 995.49K shares of EOLS, changed -9.50% as of Mar 31, 2025.
Panagora Asset holds 240.74K shares of EOLS, changed -1.39% as of Jun 30, 2025.
Hedge funds tracked by Rallies that own EOLS include Soros Fund and Panagora Asset. The latest tracked quarter is Mar 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Evolus, Inc. Common Stock.
Does Rallies show 13F holders for EOLS?
Yes. Rallies tracks hedge fund and 13F ownership data for EOLS, including fund names, share counts, latest tracked quarter, and position changes when available.
Is EOLS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for EOLS. It does not provide personalized investment advice.
